Prostate Health Supplement by Prostacet - Health and Beauty Products

Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug

Who says you can’t arrange coin investing in biotech? Vancouver, BC-based Ventures West, one of the largest dare firms in Canada, has cashed out on its booming investment in Bothell, WA-based OncoGenex Pharmaceuticals (NASDAQ: ). Ventures West disclosed earlier this week in a regulatory that it has sold all of its shares in OncoGenex-which normally would clearance with trifling remark excuse for one weighty fact. OncoGenex shares have generated a titanic returns since Dec. 2, as it has boomed from $2.25 a cut to $25.91 at yesterday’s close.

The Friends has been Riding a whiffle of zeal for its speculative Prostate Cancer drug, OGX-011, which has shown an know-how to servant men live longer in a wee Clinical Trial. Ventures West didn’t peach when it sold its shares, or at what price, so it’s unsolvable to say how much the firm pocketed from the visible record. Ventures West managing concert-master Ken Galbraith didn’t respond to a plea for comment. But here’s what I was able to tune together from the public record.

continue reading »

Related posts

• The issue must successfully complete a more far-ranging clinical trial before the U.S. (0)
• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)
• There is often significant inaugural enthusiasm for new technologies due to enormous range of technological innovation in pharmaceutical today;. (0)
• New Treatment For Prostate Cancer Pioneered. (0)
• Isis Announces That OGX (0)

There is often significant inaugural enthusiasm for new technologies due to enormous range of technological innovation in pharmaceutical today;.

UroToday.com - The Diagnosis of localised Prostate Cancer is increasing due to Increased Awareness and Increased Testing. There are a gang of curing Options elbow to many of these men, including Surgery, radiotherapy, functioning Watch and a range of new modalities including outrageous intensity focused Ultrasound (HIFU). Large Numbers of men with localised plague are looking for Treatments that minimise their morbidity (continence and Erectile Function) whilst maximising oncological effectiveness.

There is often significant primary ardour for unique technologies due to gargantuan range of technological innovation in drug today; however, Treatments for localised Prostate Cancer privation at least a 10 year backup to show efficacy over standard Techniques. Much of this hobby is generated by companies that have invested heavily in these supplemental technologies and often market them aggressively, irresponsibly and unwisely with unsophisticated data. It is suggested that HIFU is morbidity-free with better oncological outcomes than routine Treatments.

continue reading »

Related posts

• Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug (0)
• This email location is being protected from spam bots, you requirement Javascript enabled to study it Prostate cancer (PCa), (0)
• The issue must successfully complete a more far-ranging clinical trial before the U.S. (0)
• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)
• New Treatment For Prostate Cancer Pioneered. (0)

Drug recommended to slow prostate cancer in some older men

Kramer was co-chairman of the panel that Developed the advice for the American Society of Clinical Oncology and the American Urological Assn. It will be published in the March Issues of the Journal of Clinical Oncology and the Journal of Urology. The most favoured endorse candidates to hold the anaesthetize would be men who are African American or who have a chaplain or colleague with the Disease, factors which abruptly increase risk, said Dr. Jack Jacoub, a Medical oncologist at Orange Coast Memorial Medical Center in Fountain Valley, who was not a associate of the panel. Many physicians have already been prescribing it for their Patients at the highest risk, he said.

The approbation targets men with a run-of-the-mill reading on the Prostate-Specific Antigen or PSA, test, which is considered the best pointer of the shade of a Tumor, because Clinical Trials of the analgesic covered only such men. The panel stopped gruff of recommending that all men tolerate the dope because Clinical Trials have not yet shown that it reduces deaths. Prostate Cancer is the second-leading cause of Cancer deaths middle men, behind lung Cancer, with 186,000 renewed cases diagnosed and 28,660 deaths each year.

continue reading »

Related posts

• New Treatment For Prostate Cancer Pioneered. (0)
• www.tbsource.com Thunder Bay’s Source Local News 2008 (0)
• When these mouse retard cells were transplanted back into mice, they developed into wholly new glands. (0)
• When these cubicle cultures were treated with red clover isoflavones, the androgenic clobber of DHEA were reversed. (0)
• We are behind them in sentience expectancy and are less aware of our haleness issues. (0)

Cough medication may regale prostate cancer

SAN Diego, Dec. 22 (UPI) — An component in use in a run-of-the-mill cough suppressant may be useful in Treating Advanced Prostate Cancer, U.S. researchers said. The Study, published in the roll Anticancer Research, found that noscapine – occupied in cough Medication for nearly 50 years — reduced Tumor proliferation in mice by 60 percent and Little the area of Tumors by 65 percent without noxious viewpoint Effects. Dr. Israel Barken of the Prostate Cancer Research and Educational Foundation in San Diego, Moshe Rogosnitzky of MedInsight Research Institute and Dr. Jack Geller of The University of California, San Diego, said noscapine, a naturally-occurring, non-addictive by-product of opium, cannot be patented, which has minimal the stuff for Clinical Trials.

Rogosnitzky explained that panacea companies are normally unwilling to back valuable Clinical Trials without being able to recover their investment. A phoney borrowed of noscapine has been patented but has not yet reached the Clinical Testing phase. Since noscapine is approved for use in many countries as a cough suppressant, it is at to Doctors to Order for other uses as well.

continue reading »

Related posts

• When these cubicle cultures were treated with red clover isoflavones, the androgenic clobber of DHEA were reversed. (0)
• Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug (0)
• There is often significant inaugural enthusiasm for new technologies due to enormous range of technological innovation in pharmaceutical today;. (0)
• The issue must successfully complete a more far-ranging clinical trial before the U.S. (0)
• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)

IPI-504, the more advanced of the two drugs, had initially been in situation for prostate cancer -.

London, Dec 11 (Reuters) - AstraZeneca (AZN.L: , , , ) has handed back rights to two theoretical Drugs discovered by Infinity Pharmaceuticals (INFI.O: , , , ), one of which has already reached Final-Stage Phase III Clinical Testing.

The Scandal sent shares in Cambridge, Massachusetts-based Infinity 19 percent discount to $5.80 in primordial Nasdaq career on Thursday. AstraZeneca inherited the products – IPI-504 and IPI-493 — through its acquirement terminating year of U.S. biotech band MedImmune, which had clinched a deal with Infinity in 2006.

continue reading »

Related posts

• Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug (0)
• There is often significant inaugural enthusiasm for new technologies due to enormous range of technological innovation in pharmaceutical today;. (0)
• The issue must successfully complete a more far-ranging clinical trial before the U.S. (0)
• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)
• New Treatment For Prostate Cancer Pioneered. (0)

The issue must successfully complete a more far-ranging clinical trial before the U.S.

Shares of OncoGenex Pharmaceuticals nearly doubled in value on Wednesday, as the company’s speculative Prostate-Cancer Therapy showed very rosy interim Results in a midstage Clinical Trial. Patients irresistible the drug survived about 11 months longer than those winning the standard Therapy, the convention said. The Results “exceeded our expectations,” said OncoGenex Chief Executive Officer Scott Cormack. The company’s precursor closed at $3.95, up 76 percent.

The Results seem to be a coup for the newly formed company, which resulted from the blending of Sonus Pharmaceuticals, of Bothell, with Vancouver, B.C.-based OncoGenex Technologies.

continue reading »

Related posts

• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)
• Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug (0)
• Neoadjuvant/adjuvant hormonal psychotherapy has been shown to improve the result after RT. (0)
• A resultant analysis of these data suggested that Provenge improved the survival of patients with asymptomatic metastatic androgen-. (0)
• Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium (0)

The commodity must successfully complete a more enormous clinical trial before the U.S.

Shares of OncoGenex Pharmaceuticals nearly doubled in value on Wednesday, as the company’s experiential Prostate-Cancer healing showed very auspicious interim Results in a midstage Clinical Trial. Patients delightful the drug survived about 11 months longer than those fascinating the standard Therapy, the associates said. The Results “exceeded our expectations,” said OncoGenex Chief Executive Officer Scott Cormack. The company’s stereotyped closed at $3.95, up 76 percent.

The Results seem to be a coup for the newly formed company, which resulted from the fusion of Sonus Pharmaceuticals, of Bothell, with Vancouver, B.C.-based OncoGenex Technologies.

continue reading »

Related posts

• The issue must successfully complete a more far-ranging clinical trial before the U.S. (0)
• A resultant analysis of these data suggested that Provenge improved the survival of patients with asymptomatic metastatic androgen-. (0)
• Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium (0)
• Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug (0)
• This email hail is being protected from spam bots, you destitution Javascript enabled to sight it Cancer-. (0)

Free prostate cancer screenings and clinical bosom exams nearby Saturday

Men and Women will be able to get independent Prostate Cancer screenings and Clinical heart Exams Saturday from the Julie Rogers “Gift of Life” Program. Volunteer physicians will be at the Sterling Pruitt Activity Center, 2930 Gulf St., in Beaumont from 9 a.m. until 11 a.m. to purvey Prostate Cancer screenings for medically underserved men. Walk-ins are Welcome.

In Port Arthur, medically underserved Women will be able to pocket Clinical titty Exams from 9 a.m. until noonday at the Cancer Center of Southeast Texas, Ninth Avenue. Appointments are required and can be scheduled by expertise (409) 860-3369.

Regards with reverence link: click there

continue reading »

Related posts

• The commodity must successfully complete a more enormous clinical trial before the U.S. (0)
• New Treatment For Prostate Cancer Pioneered. (0)
• Men desideratum better prostate cancer edification programs (0)
• Led by Laura Esserman, M.D., MBA, the center is separate of the UCSF Helen Diller Family Comprehensive Cancer Center, (0)
• Green tea may slack prostate cancer (0)

New Treatment For Prostate Cancer Pioneered.

The remodelled Treatment-magnetic resonance imaging (MRI)-guided Transurethral Ultrasound-uses fervidness from focused Ultrasound to attend Cancer in the Prostate Gland scrupulously while mingy the dainty Noncancerous tissues around the Prostate Essential for in good urinary, Bowel and Sexual Function. Sunnybrook researchers Dr. Michael Bronskill and Dr. Rajiv Chopra have licensed their novelty and formed Profound Medical Inc., which will cultivate the technology for Clinical use.

Unlike surgical ouster of the Prostate, the Therapy is minimally invasive and could be performed without a over-long convalescent home stay. In preclinical Studies, healing takes less than 30 minutes. The Therapy, on which clinicians at Sunnybrook will Running prior Testing in preparation for a Clinical Trial, could ease limit the Number of men Living with the common, debilitating and often imperishable side belongings of Surgery and Radiation Treatments currently used. More of these invasive therapies are being performed now because improved Awareness to each younger men has converged with better Clinical Detection tools.

continue reading »

Related posts

• Ultrasound prostate cancer thingumajig touted (0)
• Drug recommended to slow prostate cancer in some older men (0)
• www.tbsource.com Thunder Bay’s Source Local News 2008 (0)
• When these mouse retard cells were transplanted back into mice, they developed into wholly new glands. (0)
• When these cubicle cultures were treated with red clover isoflavones, the androgenic clobber of DHEA were reversed. (0)